See other companies on Welcome to the Jungle

Neotiv

Alzheimer's screening health app

Neotiv logo
21-100 employees
  • Healthcare
  • B2B
  • Mobile
  • MedTech
Altstadt, Magdeburg, Germany

Jump to section

Company mission

To provide early medical evaluation and monitoring of memory problems associated with Alzheimer's disease.

Our take

There are an estimated 32 million people living with Alzheimer's globally, a number that rises to 100 million if people suspected to be in the early phases of the disease are included. While early detection greatly increases the treatment options and outcomes, until now it has been a difficult condition to detect before its late stages.

Neotiv is a German medtech startup which produces the neotivCare app, a digital therapeutic device which is rated as a CE class I medical device. It is capable of early detection of Alzheimer's, catching it when it presents as memory lapses and mild cognitive decline, and allowing for the application of early treatment.

After extensive use in care projects across Germany, neotiv has secured significant investment funding from medtech-focused venture capital funds. This will be used to grow the company and develop the product with new features to aid in early detection of cognitive decline. It is also planning to expand internationally, bringing vital tools to the global fight against Alzheimer's.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • A great team that enjoys its work and at the same time has high standards of quality and professionalism
  • Free hot and cold drinks in the office are a matter of course for us
  • Professional collaboration with renowned scientists from leading institutions
  • Monthly Creative Freedom Days, where you can fully dedicate yourself to your personal development!
  • Flexible working hours and a high vacation entitlement
  • An informal working environment with short communication and decision-making paths
  • You decide: Work from a home office or in an office with high-quality office equipment
  • A structured onboarding process, regular feedback sessions, and training opportunities tailored to your needs as agreed upon
  • Regular team meetings and team events (offline and online)

Funding (1 round)

Nov 2022

$10.6m

SEED

Total funding: $10.6m

Leadership

Chris Rehse

(CEO)

Also co-founder of NAVAN Technologies and FabLab Incubator Magdeburg. While completing a Postdoc. in Biomedical/Medical Engineering, was also a Project Manager at the Transfer and Startup Centre at the Otto-von-Guericke-University Magdeburg.

David Berron

(CSO)

Is also a Postdoctoral Researcher at Lund University and Research Group Leader for the German Center for Neurodegenerative Diseases.

Julian Haupenthal

(CPO)

Co-founder and CPO of Neotiv.

Emrah Duzel

(Chief Medical Officer)

As well as co-founding Neotiv, is a Professor at UCL, Site Representative for the German Center for Neurodegenerative Diseases, a Fellow of the Max-Planck School of Cognition and Institute Director at the Medical faculty of the Otto-von-Guericke-University Magdeburg.